Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05JRZ
|
||||
Former ID |
DNC006829
|
||||
Drug Name |
NSC-27236
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528283] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H11N3O5S
|
||||
Canonical SMILES |
C1=CC(=CC=C1NN=C2C=CC(=O)C(=C2)C(=O)O)S(=O)(=O)N
|
||||
InChI |
1S/C13H11N3O5S/c14-22(20,21)10-4-1-8(2-5-10)15-16-9-3-6-12(17)11(7-9)13(18)19/h1-7,15H,(H,18,19)(H2,14,20,21)/b16-9-
|
||||
InChIKey |
BLGKPMXPJZAYFD-SXGWCWSVSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [528283] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.